Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2016 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2020 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2016 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.050 |
None |
0.800 |
5 |
|
2000 |
2006 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.050 |
None |
0.800 |
5 |
|
1999 |
2012 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.050 |
None |
0.800 |
5 |
|
2001 |
2019 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2016 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2016 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2018 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2018 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2018 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.320 |
None |
1.000 |
4 |
|
2011 |
2016 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2007 |
Proliferative Inflammatory Atrophy
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
24
|
|
0.040 |
None |
0.750 |
4 |
|
2001 |
2004 |
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
462
|
79
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2009 |
Complete atrioventricular block
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
403
|
96
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2018 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.040 |
None |
1.000 |
4 |
|
2007 |
2019 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Malignant tumor of cervix
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1718
|
245
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2018 |
Hepatitis B, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
415
|
84
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2018 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.040 |
None |
0.750 |
4 |
|
2000 |
2006 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Peptic Esophagitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
85
|
3
|
0.030 |
None |
0.667 |
3 |
|
2006 |
2010 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.030 |
None |
0.333 |
3 |
|
2005 |
2015 |